MAOB and Parkinson disease: Similarly, there are no standard neuroprotective medications in PD treatment able to cease disease progression, although monoamine oxidase-B inhibitors (MAO-B) or dopamine receptor agonists may have neuroprotective as well as symptomatic effects [17,18,19].